Source: FDA, National Drug Code (US) Revision Year: 2020
Noxivent (nitric oxide gas) is a drug administered by inhalation. Nitric oxide, the active substance in Noxivent, is a pulmonary vasodilator. Noxivent is a gaseous blend of nitric oxide and nitrogen (0.08% and 99.92%, respectively for 800 ppm; 0.01% and 99.99%, respectively for 100 ppm). Noxivent is supplied in aluminum cylinders as a compressed gas under high pressure (2000) pounds per square inch gauge [psig]).
The structural formula of nitric oxide (NO) is shown below:
| Dosage Forms and Strengths |
|---|
|
Noxivent (nitric oxide) gas is available in 100 ppm and 800 ppm concentrations. |
| How Supplied | ||||||||
|---|---|---|---|---|---|---|---|---|
|
Noxivent (nitric oxide) is available in the following sizes:
All regulations concerning handling of pressure vessels must be followed. Protect the cylinders from shocks, falls, oxidizing and flammable materials, moisture, and sources of heat or ignition. Occupational Exposure: The exposure limit set by the Occupational Safety and Health Administration (OSHA) for nitric oxide is 25 ppm, and for NO2 the limit is 5 ppm. Distributed by: Praxair Distribution, Inc., 10 Riverview Drive, Danbury, CT 06810-6268 |
| Drug | Countries | |
|---|---|---|
| NOXIVENT | Canada, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
